Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cholesgen logo — Pioneering the future of medicine through groundbreaking dru...

Cholesgen

Pioneering the future of medicine through groundbreaking drug development and advanced biopharmaceutical research.

Founded 2021 Series A Total: $100.00M Biotechnology, Pharmaceutical

General Information

Company Name Cholesgen
Founded Year 2021
Industries Biotechnology, Pharmaceutical
Funding Stage Series A
Social

Get notified when Cholesgen moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cholesgen

Cholesgen is a biopharmaceutical company founded in 2021 with a mission to revolutionize medicine through innovative drug development and advanced biopharmaceutical research. The company's dedication to pioneering new disease targets based on biochemistry, disease biology, medicinal chemistry, and clinical translational medicine sets it apart in the Biotechnology and Pharmaceutical industries. In June 2023, Cholesgen secured a significant CNY100.00M Series A investment from a syndicate of influential backers including Gaorong Capital, Dawu Venture Capital, AstraZeneca CICC Medical Industry Fund, Sany Innovation Investment, and Nanwan Baiao Fund. This injection of capital signifies a vote of confidence in Cholesgen's innovative approach to drug development and its potential to leave a lasting impact on the future of medicine.

Taxonomy: biopharmaceutical research, drug development, innovative drugs, disease targets, biochemistry, medicinal chemistry, clinical translational medicine, pharmaceutical industry, medical innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 5
Investor Investor
•••• •••• 		06 Jun 2023

Cholesgen Alternatives & Competitors

Cholesgen vs
remynd
remynd Belgium

Remynd is a clinical-stage biotechnology company dedicated to developing first-in-class oral therape...

Series B
30 employees
Biotechnology, Manufacturing
Compare Cholesgen vs remynd
Cholesgen vs
Satori Pharmaceuticals
Satori Pharmaceuticals

Pioneering advanced therapies for Alzheimer's, Parkinson's, and other neurodegenerative diseases.

Series Unknown
Health Care, Pharmaceutical
Cholesgen vs
ImStar Therapeutics Inc.
ImStar Therapeutics Inc. Canada

Breakthrough science & promising new treatments giving hope to patients with ALS & neurodegenerative...

Unknown
3 employees
Biotechnology, Health and Wellness

FAQ About Cholesgen

Pioneering the future of medicine through groundbreaking drug development and advanced biopharmaceutical research.
Cholesgen was founded in 2021.
Cholesgen operates in the following industries: Biotechnology, Pharmaceutical.
Cholesgen has completed 1 funding round, raising a total of $100.00M. The latest funding stage is Series A.
Top alternatives and competitors to Cholesgen include remynd, Satori Pharmaceuticals, ImStar Therapeutics Inc., Aramis Biosciences, Tenaya Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cholesgen and remynd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cholesgen and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy